Absci(US:ABSI) ZACKS·2024-08-14 22:31分组1 - Absci Corporation reported a quarterly loss of $0.22 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.19, and an improvement from a loss of $0.27 per share a year ago [1] - The company's revenues for the quarter ended June 2024 were $1.27 million, missing the Zacks Consensus Estimate by 37.93%, and down from $3.37 million in the same quarter last year [1] - Absci Corporation has not surpassed consensus EPS and revenue estimates over the last four quarters [1] 分组2 - The stock has underperformed, losing about 7.6% since the beginning of the year, while the S&P 500 has gained 13.9% [2] - The company's earnings outlook is mixed, with a current consensus EPS estimate of -$0.19 on revenues of $1.81 million for the coming quarter, and -$0.80 on revenues of $7.42 million for the current fiscal year [4] - The Medical - Biomedical and Genetics industry, to which Absci belongs, is currently in the top 29% of Zacks industries, indicating a favorable industry outlook [5]